×
Including results for keros investor relations
Search only for kerx investor relations
The Investor Relations website contains information about Keros Therapeutics's business for stockholders, potential investors, and financial analysts.
Missing: kerx | Show results with:kerx
Corporate Presentation March 2024 · Hematology Franchise Investor Call Presentation December 2023 · KER-012 Investor Call Deck August 2023. Investors & Media.
Missing: kerx | Show results with:kerx
IR Contacts. Company. Kiora Pharmaceuticals, Inc. 332 Encinitas Boulevard Suite 102. Encinitas, CA 92024. Investor Relations. Investors investors@kiorapharma.
Missing: kerx | Show results with:kerx
KERX Keryx Biopharmaceuticals, Inc. (delisted). NASDAQ. 3,36. 0,00 (0,00 ... keryx.com within the Investor Relations section under “webcasts and presentations.
Keryx Biopharmaceuticals will host an investor conference call today, August 8, 2018, at 8:00 a.m. ET to discuss financial results for the second quarter of ...
(KERX) CEO Jodie Morrison on Q2 2018 Results - Earnings Call Transcript · SA TranscriptsWed, Aug. 08, 20188 Comments · Akebia Keryx Merger Investor Presentation.
Missing: relations | Show results with:relations
Investor Relations. Overview · News & Events · Press ... As previously announced, Keryx shareholders are ... Reports on Form 10-Q, Current Reports on Form 8-K, the ...
Keryx is headquartered in New York City. KERYX CONTACT: Lauren Fischer. Director - Investor Relations. Keryx Biopharmaceuticals, Inc. Tel: 212.531.5965.
Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) institutional ownership structure shows current positions in the company by institutions and funds, as well as ...
Keryx Bio Pharmaceuticals Investor Relations · Yahoo Finance Page · Morningstar Page · MSN Money Page · SeekingAlpha · The Motley Fool · TheStreet.com · Google Finance ...